Deoxyarbutin targets mitochondria to trigger p53-dependent senescence of glioblastoma cells

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Cellular senescence acts as a barrier against cancer progression.
• Inducing senescence pharmacologically is a potential anticancer approach.
• Glioblastoma (GBM) is an aggressive brain tumor with limited treatment options.

Purpose of the Study:

• To investigate the mechanism by which deoxyarbutin inhibits glioblastoma growth.
• To determine if deoxyarbutin-induced senescence is linked to tyrosinase expression.
• To explore the role of mitochondrial oxidative stress and p53 in deoxyarbutin's effects on GBM cells.

Main Methods:

• Treatment of glioblastoma cells with deoxyarbutin.
• Assessment of cellular senescence markers.
• Analysis of mitochondrial oxidative stress and damage.
• Investigation of p53 pathway activation.
• Evaluation of tumor growth in a mouse model.

Main Results:

• Deoxyarbutin inhibited glioblastoma cell growth by inducing cellular senescence, independent of tyrosinase.
• Deoxyarbutin caused mitochondrial oxidative stress and damage, which were crucial for p53-dependent senescence.
• Modulating autophagy or mitigating mitochondrial stress reduced p53 expression and senescence.
• Deoxyarbutin treatment led to p53 accumulation, senescence induction, and tumor growth inhibition in vivo.

Conclusions:

• Deoxyarbutin induces p53-dependent cellular senescence in glioblastoma cells through mitochondrial oxidative stress.
• Deoxyarbutin demonstrates therapeutic potential for glioblastoma treatment.